Osteonecrosis of the jaw is a possible oral complication resulting from antiresorptive therapies, such as bisphosphonates (Bfs).
Although the etiology is not entirely clear, it has been shown to be dependent on several factors, with the traumatic stimulation caused by the placement of teeth implants indicated as one of the predisposing factors to this pathology.
The indications and preventive methods for performing these procedures have been questioned, making it essential to determine the proper protocols.
Thus, the present study aims to discuss the risks of the development of osteonecrosis in patients undergoing dental implant surgery who use Bfs as well as to discuss related local and systemic factors and possible methods for preventing this side effect.
The study also aims to present a clinical case of an osteopenic patient who used Bfs and underwent rehabilitation through implants according to specific protocols, which resulted in successful treatment.
Bfs promote a clear risk of osteonecrosis development in the jaw.
The duration of therapy and type and administration method of the Bfs are factors directly related to the onset of this pathology.
Bone trauma through the installation of osseointegratable implants is a predisposing factor of the disease.
Therefore, its indication must be carefully evaluated, and if this treatment is chosen, preventive measures should be taken, such as the interruption of the use of Bfs, antibiotic prophylaxis use prior to surgery, and adequate prosthetic rehabilitation.
